Clinical Trials & Medical Discoveries The most recent news and results from scientific and medical research, covering all aspects of healthcare, including testing, diagnosis, and treatment. Stay up-to-date on the latest medical discoveries and breakthroughs with announcements of new products to be tested, upcoming clinical trials and studies, and newly published results. Also included are updates regarding funding decisions, company performance, and legal news.

Latest

Aug 11, 2017, 09:32 ET Spoločnosť Swift ponúka metódu prípravy knižnice s najvyššou priepustnosťou na báze metylačného bunkového sekvencovania

Štúdia publikovaná v časopise Science demonštruje, ako dokážu epigenetické markery identifikovať bunkové podtypy a regulačné prvky, ktoré stoja v...


Aug 11, 2017, 08:13 ET Swift présente la méthode la plus rapide pour la préparation de bibliothèques en vue du séquençage unicellulaire par méthylation à haut rendement

Une étude parue dans la revue Science montre comment les marqueurs épigénétiques permettent d'identifier les sous-types de cellules et les éléments...


Aug 11, 2017, 07:00 ET Ionis to Independently Advance Inotersen and IONIS-FB-L Rx

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) today reported that the Company has retained all rights to inotersen and IONIS-FB-LRx. As part...


Aug 11, 2017, 06:45 ET Swift publikuje metodę przygotowywania bibliotek metylacji pojedynczych komórek o najwyższej przepustowości

Badania opublikowane w magazynie „Science" wyjaśniają, jak markery epigenetyczne mogą prowadzić do identyfikacji podtypów komórek i elementów...


Aug 11, 2017, 04:27 ET Компания Swift представляет метод подготовки геномных библиотек секвенирования с одноклеточным метилированием и высочайшей пропускной способностью

Результаты исследования, опубликованные в журнале Science, демонстрируют способность эпигенетических маркеров идентифицировать подвиды клеток и...


Aug 10, 2017, 20:56 ET Swift anuncia el método de preparación de bibliotecas con secuenciación para metilación de una sola célula de mayor rendimiento

Swift Biosciences, un proveedor líder de soluciones innovadoras de preparación de bibliotecas para la secuenciación de próxima generación (NGS, por...


Aug 10, 2017, 20:15 ET Healthcare Laws Authorize Practices That Were Criticized by State Auditor in Recent Hospital Report

Hospital Partners Inc. issued the following statements and information regarding the MO State Auditor's recent report. As a rural hospital /...


Aug 10, 2017, 19:46 ET Swift anuncia método de preparação de biblioteca de sequenciamento de metilação de célula única do mais alto rendimento

A Swift Biosciences, destacada fornecedora de soluções inovadoras de preparação de biblioteca de sequenciamento de nova geração (NGS --...


Aug 10, 2017, 15:36 ET Swift Announces the Highest Throughput Single-Cell Methyl-Seq Library Preparation Method

Swift Biosciences, a leading provider of innovative library prep solutions for next-generation sequencing (NGS), today announced the launch of a...


Aug 10, 2017, 14:13 ET Mutant Ants Provide Insights into Social Interaction

Ants genetically engineered to lack their "sense of smell" became unable to communicate, forage or compete to be a queen, as their antennae and...


Aug 10, 2017, 13:12 ET Changes Afoot in the Management of CKD Mineral Bone Disorder Reinforced by a Clinical Practice Guideline Update from KDIGO

Since the introduction of Renagel by Genzyme Corporation nearly 20 years ago, the use of non-calcium binders has been steadily gaining ground,...


Aug 10, 2017, 08:00 ET Audentes Therapeutics Reports Second Quarter 2017 Financial Results and Provides Corporate Update

Audentes Therapeutics, Inc. (Nasdaq: BOLD), a biotechnology company focused on developing and commercializing gene therapy products for patients...


Aug 10, 2017, 08:00 ET Sutro & Celgene to Refocus 2014 Immuno-Oncology Collaboration on Four Programs

Sutro Biopharma today announced it is refocusing its 2014 immuno-oncology collaboration with Celgene on four programs that are advancing through...


Aug 09, 2017, 11:00 ET IDTechEx Research Releases new Report on Neuroprosthetics, an $18 Billion Market by 2028

The new IDTechEx Research report, Neuroprosthetics 2018-2028: Technologies, Forecasts, Players, covers the competitive landscape for cochlear...


Aug 09, 2017, 09:30 ET Hip Innovation Technology Initiates Clinical Trial of its Novel Hip Replacement System for the Treatment of Total Hip Arthroplasty

Hip Innovation Technology, LLC (HIT), a medical device company developing innovative orthopedic device solutions to advance the quality of life and...


Aug 09, 2017, 08:30 ET PharmaMar Starts a Quadruple Combination Study With Aplidin® for the Treatment of Multiple Myeloma

- Aplidin® is an ideal compound for combining with other therapies given its absence of Hematological toxicity, excellent safety...


Aug 09, 2017, 08:30 ET Neurotrope Provides Business Update and Reports Second Quarter 2017 Financial Results

Neurotrope, Inc. (NASDAQ: NTRP), a clinical-stage biopharmaceutical company developing novel therapies for neurodegenerative diseases, including...


Aug 09, 2017, 08:00 ET BioSight Completed Patient Enrollment and Treatment in its Extended Acute Leukemia Phase I/II Clinical Trial with BST-236, a Novel Cytarabine Pro-Drug

BioSight, Ltd, a pharmaceutical development company, focused on the development of targeted oncology therapeutics with reduced toxicity, today...


Aug 09, 2017, 08:00 ET CureLab Oncology publishes proof of concept demonstrating that its product can reduce metabolic disorders induced by excessive food consumption.

The journal Oncotarget published a pre-print of the research conducted by CureLab Oncology, Inc. The paper proposes the concept of the "vicious...


Aug 09, 2017, 07:15 ET Ocugen Receives FDA Orphan Drug Designation for OCU300 (brimonidine tartrate) for the Treatment of Ocular Graft Versus Host Disease

Ocugen, Inc., a clinical stage biopharmaceutical company developing novel treatments for sight-threatening diseases, today announced the U.S. Food...


Most Viewed